Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses

By sjmartinez • September 13, 2024

Lebwohl MG, Armstrong AW, Alexis AF, Lain EL, Jacobson AA. Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses. Dermatol Ther (Heidelb). 2024 Sep 12. doi: 10.1007/s13555-024-01264-3. Epub ahead of print. PMID: 39264399.

Tags: Alcohol, biologic therapy, Dermatology, IL-17 receptor A inhibitor, Obesity, plaque psoriasis, Publications, Tobacco

Related Posts

Multicytokine-based transcriptome-wide association study for 7 inflammatory skin disorders identifies candidate causal genes in keratinocytes

Zhang H, Patrick MT, Sarkar MK, Bogle R, Li Q, Uppala R, Perez White BE, Petukhova L, Dand N, Stuart PE, Christiano AM, Simpson MA,[...]

Safety and Efficacy of Deucravacitinib in Japanese Patients With Moderate to Severe Plaque Psoriasis: 5-Year Analysis of the Phase 3 POETYK PSO-1, PSO-4, and Long-Term Extension Trials

Okubo Y, Morita A, Tada Y, Imafuku S, Armstrong AW, Blauvelt A, Vaile J, Popmihajlov Z, Li J, Sawant R, Habiro K, Tsuritani K, Ohtsuki[...]

In search of a cure for pemphigus

Kasperkiewicz M. In search of a cure for pemphigus. Br J Dermatol. 2026 Aug 6:ljag326. doi: 10.1093/bjd/ljag326. Epub ahead of print. PMID: 42557880.